基本情況:許金紅，女，呼吸内科學博士研究生，副主任醫師，貴州省銅仁市人民醫院腫瘤内科學碩士研究生導師。長期從事胸部腫瘤的化療、靶向、免疫及放射性治療等臨床工作，同時長期從肺癌的發病機制、中藥抗腫瘤的作用及機制研究，在腫瘤生物信息學、循證醫學，靶向藥物聯合免疫治療等領域開展研究。主持貴州省衛生健康委基金項目和貴州省科技廳基礎研究計劃項目。在《中國防痨雜志》、World journal of surgical oncology,Biomed Environ Sci,Public Health Nurs.,Chinese Medical Journal等國内外核心起開上發表論文8篇。
聯系方式：Email:1072486320@qq.com
代表性論文（*：通訊作者）:
1.許金紅，楊渝浩，董德瓊，中期因子在肺癌中的表達及臨床意義，《臨床内科雜志》，2007，24（2）：130-131.
2.Xu JH, Yang HP#, Zhou XD, Wang HJ, Gong L, Tang CL. Autophagy Accompanied with Bisdemethoxycurcumin-induced Apoptosis in Non-small Cell Lung Cancer Cells.Biomed Environ Sci, 2015, 28(2):105-115.
3.Jin-Hong Xu, He-Ping Yang*, Xiang-Dong Zhou, Hai-Jing Wang, Liang Gong, Chun-Lan Tang. The role of Wnt inhibitory factor 1 (WIF-1) in inhibition of bisdemethoxycurcumin mediated EMT in highly metastatic lung cancer 95D cells.Chinese Medical Journal. 2015,128(10):1376-1383.
4.Jinhong XU, Heping YANG#, Xiangdong ZHOU, Haijing WANG, Liang GONG, Chunlan, TANG.Bisdemethoxycurcumin Suppresses Migration and Invasion of Highly Metastatic Lung Cancer 95D Cells by inducing autophagy,Molecular Medicine Reports.2015, 12:7603-7608.
5.Bu X1, Zhang X2,Xu J3,#, Yang H4, Zhou X4, Wang H4, Gong L4. Inhibition of DNA methyltransferase 1 by RNA interference reverses epithelial to mesenchymal transition in highly metastatic lung cancer 95D cells by inhibiting Wnt signaling pathway.Oncology letters. 2018, 15(6):9242-9250.
6.許金紅, 楊松, 張立新,等. 中國耐多藥結核病發病危險因素的Meta分析[J].中國防痨雜志, 2019, 041(012):1301-1309.
7.Segmental artery clamping versus main renal artery clamping in nephron-sparing surgery: updated meta-analysis.Jinhong Xu1†, Shuxiong Xu2† , Biao Yao3 , Run Xu3 , Yuangao Xu2 , Fa Sun2 , Qian Qiu4 and Hua Shi1* .World Journal of Surgical Oncology[J],2020,210（1）1-16.
8.Mei Feng1,a, Yuangao, XU1,a, Xiangyan Zhangb, Qian Qiuc , Shiguang Leid, JingLan LIf, W ei YUAN f, Qunfeng Song f ,Jinhong Xu*,f，Risk factors of m ultidrug resistant tuberculosis in China: a m eta-analysis.Public Health Nurs.2019;00:1–137.
